Tech Company Financing Transactions
Amplimmune Funding Round
Amplimmune closed a funding round on 6/30/2008. Backers included InterWest Partners.
Transaction Overview
Company Name
Announced On
6/30/2008
Transaction Type
Venture Equity
Amount
Unknown
Round
Undisclosed
Investors
InterWest Partners (Arnold Oronsky)
Proceeds Purpose
Proceeds purposes were not disclosed.
Company Information
Company Status
Acquired or Merged
Industry
Biopharmaceutical
Mailing Address
45 W Watkins Mill Rd Suite A
Gaithersburg, MD 20878
USA
Gaithersburg, MD 20878
USA
Phone
Website
Email Address
Not Recorded
Overview
Founded in 2007 and headquartered in Gaithersburg, MD, Amplimmune is focused on developing novel co-stimulatory/co-inhibitory molecules that rebalance the immune system and are intended for treating cancer, autoimmune disease, infectious disease, and transplantation.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Michael Richman
Browse more venture capital transactions:
Prev: 6/30/2008: Demandware venture capital transaction
Next: 6/30/2008: PerQuest venture capital transaction
Share this article
About Our Venture Capital Transactions Database
We do our best to record every notable VC transaction. All VC database entries reported here come from a variety of public sources. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs